Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 30.54 M31.95 M29.13 M30.17 M29.53 M 120.78 M Research & development ————— — Operating income 16.47 M30.43 M11.89 M16.93 M28.42 M 87.67 M Non-Operating Income, Total 582 K-6.63 M3.65 M3.73 M3.65 M 4.41 M Interest expense, net of interest capitalized 11.7 M12.98 M13.91 M13.71 M11.28 M 51.87 M Non-Operating Income, excl. Interest Expenses -12.68 M-21.91 M-13.41 M-13.92 M-9.16 M -58.4 M Unusual income/expense 1.56 M2.3 M3.16 M3.94 M1.53 M 10.93 M Pretax income 5.35 M10.81 M1.46 M7.16 M18.68 M 38.11 M Equity in earnings ————— — Taxes 98 K37 K137 K-2.02 M122 K -1.72 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 5.25 M10.77 M1.32 M7.22 M18.56 M 37.87 M Discontinued operations ————— — Net income 5.25 M10.77 M1.32 M7.22 M18.56 M 37.87 M Dilution adjustment -62 K-62 K-62 K—-73 K — Preferred dividends 3.93 M3.93 M4.26 M—2.6 M — Diluted net income available to common stockholders 1.26 M6.78 M-3 M3.17 M15.88 M 22.83 M Basic earnings per share (Basic EPS) 0.010.03-0.020.020.08 0.11 Diluted earnings per share (Diluted EPS) 0.010.03-0.020.020.08 0.11 Average basic shares outstanding 200.41 M195.79 M189.25 M193.61 M188.36 M — Diluted shares outstanding 201.44 M196.3 M189.25 M194.32 M188.67 M — EBITDA 49.61 M65.87 M47.56 M53.26 M63.64 M 230.34 M EBIT 16.47 M30.43 M11.89 M16.93 M28.42 M 87.67 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 33.14 M35.45 M35.67 M36.34 M35.22 M 142.67 M